KPIs & Operating Metrics(New)
Growth Metrics

Charles River Laboratories International (CRL) Gross Profit (2016 - 2025)

Charles River Laboratories International has reported Gross Profit over the past 17 years, most recently at $744.9 million for Q4 2025.

  • Quarterly results put Gross Profit at $744.9 million for Q4 2025, up 305.17% from a year ago — trailing twelve months through Dec 2025 was $2.2 billion (up 41.55% YoY), and the annual figure for FY2025 was $3.4 billion, up 46.17%.
  • Gross Profit for Q4 2025 was $744.9 million at Charles River Laboratories International, up from $596.7 million in the prior quarter.
  • Over the last five years, Gross Profit for CRL hit a ceiling of $1.9 billion in Q4 2021 and a floor of -$363.1 million in Q4 2024.
  • Median Gross Profit over the past 5 years was $473.6 million (2022), compared with a mean of $589.4 million.
  • Biggest five-year swings in Gross Profit: crashed 152.25% in 2024 and later soared 305.17% in 2025.
  • Charles River Laboratories International's Gross Profit stood at $1.9 billion in 2021, then crashed by 73.94% to $496.7 million in 2022, then surged by 39.91% to $695.0 million in 2023, then tumbled by 152.25% to -$363.1 million in 2024, then soared by 305.17% to $744.9 million in 2025.
  • The last three reported values for Gross Profit were $744.9 million (Q4 2025), $596.7 million (Q3 2025), and $447.3 million (Q2 2025) per Business Quant data.